Fractional Flow Reserve derived from Computed Tomography, often shortened to FFRCT, is a noninvasive way to determine whether a narrowing in a coronary artery actually reduces blood flow to the heart muscle. Coronary arteries can look narrowed on imaging, but not all narrowings block blood flow enough to cause symptoms or increase risk. FFRCT helps answer the more important question: does this narrowing matter physiologically?
The test starts with a coronary CT angiogram, which is a high resolution scan that shows the anatomy of the heart’s arteries. Advanced computer modeling is then applied to simulate how blood would flow through those arteries under stress conditions. This allows calculation of fractional flow reserve, which is the ratio of blood pressure after a narrowing compared to before it. A value above 0.80 generally means blood flow is adequate, while values at or below 0.80 suggest the narrowing is limiting oxygen delivery to the heart muscle and may cause ischemia, which means insufficient blood supply.
This distinction is critical. Many people have moderate plaque buildup that looks concerning on imaging but does not significantly impair blood flow. Treating those lesions with stents or invasive procedures does not improve outcomes and exposes patients to unnecessary risk. FFRCT helps avoid this by identifying which lesions are unlikely to cause harm and which deserve closer attention.
When FFRCT values are normal, patients have very low rates of heart attack, urgent revascularization, or cardiac death over follow up. This makes FFRCT a strong gatekeeper test that can safely defer invasive coronary angiography. When FFRCT values are abnormal, the risk of major adverse cardiac events is higher, and targeted interventions such as medication intensification or revascularization become more clearly justified.
FFRCT also adds value when standard CT angiography is ambiguous. Heavy calcification can make arteries look more obstructed than they truly are, leading to false positives. While extreme calcium burden can reduce accuracy, FFRCT still improves specificity compared to anatomy alone in many patients, especially those with intermediate risk profiles.
Compared with stress tests like SPECT or PET, FFRCT offers vessel level precision. Instead of saying whether the heart as a whole shows reduced blood flow, it identifies exactly which artery and which segment is responsible. That said, FFRCT reflects simulated blood flow rather than direct measurement, and image quality matters. Irregular heart rhythms, very high heart rates, or severe calcification can limit reliability.
In practical terms, FFRCT shifts the focus from how blocked an artery looks to how the heart actually functions. That shift aligns closely with modern prevention focused cardiology, where the goal is to identify clinically meaningful disease early while avoiding unnecessary procedures.